A forecast of the year by Bill Kerr, M.D., MBA, CEO of Avalon Healthcare Solutions.
As 2025 approaches, the healthcare landscape is undergoing rapid transformation. Rising healthcare utilization, escalating costs and surging demand for specialized drugs like GLP-1 [glucagon-like peptide 1] therapies are intensifying the need for innovative solutions. One critical strategy lies in harnessing the power of lab data.
Kerr
By leveraging comprehensive lab insights, payers and employers can identify patients eligible for targeted treatments, stratify them by risk and ensure that costly medications are prescribed judiciously. This data-driven approach not only helps manage expenses but also improves patient outcomes.
Conversations With Perry and Friends: Paul Fronstin, Ph.D.
May 9th 2025Perry Cohen, Pharm.D., a longtime member of the Managed Healthcare Executive editorial advisory board, is host of the Conversations with Perry and Friends podcast. In this episode, his guest is Paul Fronstin, Ph.D., director of health benefits research at the Employee Benefit Research Institute.
Listen
Conversations With Perry and Friends
April 14th 2025Perry Cohen, Pharm.D., a longtime member of the Managed Healthcare Executive editorial advisory board, is host of the Conversations with Perry and Friends podcast. His guest this episode is John Baackes, the former CEO of L.A. Care Health Plan.
Listen